Increased cost of illness among European patients with type 2 diabetes treated with insulin

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Current Medical Research and Opinion

• Publication date

  2017-01-02

• Fields of study

  Medicine

• Identifiers
  DOI 10.1080/03007995.2016.1233099PMID 27595332
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Unit Costs of Health and Social Care 2016

  2015cited by this paper
• Reference NHS

  2014cited by this paper
• Impact of therapy escalation on ambulatory care costs among patients with type 2 diabetes in France

  2013cited by this paper
• Management of Hyperglycemia in Type 2 Diabetes: A Patient-Centered Approach

  2012cited by this paper
• Diabetes expenditure, burden of disease and management in 5 EU countries

  2012cited by this paper
• Insulin therapy for diabetes mellitus: treatment regimens and associated costs.

  2012cited by this paper
• Cost of Self-Monitoring of Blood Glucose in the United States Among Patients on an Insulin Regimen for Diabetes

  2012cited by this paper
• Self-monitoring of blood glucose in patients with type 2 diabetes mellitus who are not using insulin.

  2012cited by this paper
• Management of hyperglycaemia in type 2 diabetes: a patient-centered approach. Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)

  2012cited by this paper
• [Cost-effectiveness of the combination therapy of dutasteride and tamsulosin in the treatment of benign prostatic hyperlasia in Spain].

  2011cited by this paper
• Medical Management of Hyperglycemia in Type 2 Diabetes: A Consensus Algorithm for the Initiation and Adjustment of Therapy

  2009cited by this paper
• Direct costs and health-related resource utilisation in the 6 months after insulin initiation in German patients with type 2 diabetes mellitus in 2006: INSTIGATE study*

  2008cited by this paper
• Cost-effectiveness of ranibizumab compared with photodynamic treatment of neovascular age-related macular degeneration.

  2008cited by this paper
• [Costs of the treatment of hyperglycemia in patients with diabetes mellitus. The impact of age, type of therapy and complications: results of the German CoDiM study].

  2006cited by this paper
• Cost of scheduled and unscheduled asthma management in seven European Union countries

  2006cited by this paper
• Self-monitoring of blood glucose in patients with type 2 diabetes mellitus who are not using insulin.

  2005cited by this paper
• Analysis of Cost and Utilization of Health Care Services Before and After Initiation of Insulin Therapy in Patients With Type 2 Diabetes Mellitus

  2003cited by this paper
• Revealing the cost of Type II diabetes in Europe

  2002cited by this paper
• Health care costs associated with escalation of drug treatment in type 2 diabetes mellitus.

  2001cited by this paper
• The Validity and Reproducibility of a Work Productivity and Activity Impairment Instrument

  1993cited by this paper
• A new method of classifying prognostic comorbidity in longitudinal studies: development and validation.

  1987cited by this paper
• Organization for Economic Cooperation and Development

  1962cited by this paper

• Exploring cost drivers to improve disease management: the case of type 2 diabetes at a tertiary hospital in Burundi, Africa

  2023cites this paper
• The burden of type 2 diabetes in Europe: current and future aspects of insulin treatment from patient and healthcare spending perspectives.

  2020cites this paper
• Investigation on the association between diabetes distress and productivity among patients with uncontrolled type 2 diabetes mellitus in the primary healthcare institutions.

  2020cites this paper
• Effectiveness of premixed insulin to achieve glycaemic control in type 2 diabetes: A retrospective UK cohort study

  2020cites this paper